| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |